Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)

~19 mi. (Regensburg, Germany, +93 more cities)

Caritas Krankenhaus St. Josef ( Site 0502)

Bladder Carcinoma, +1 more condition

cisplatin, +4 more drugs

chemotherapy, +3 more types

Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015)

~19 mi. (Regensburg, Germany, +131 more cities)

Universitaetsklinikum Regensburg ( Site 1203)

HER2 Negative

Adenocarcinoma of the Gastroesophageal Junction, +2 more conditions

CAPOX regimen, +3 more drugs

chemotherapy, +2 more types

A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (LEAP-010) (MK-7902-010)

~19 mi. (Regensburg, Germany, +127 more cities)

Universitaetsklinikum Regensburg ( Site 2100)

Hypopharyngeal Squamous Cell Carcinoma, +3 more conditions

lenvatinib, +1 more drug

immunotherapy, +1 more type

TAK-788 as First-line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

~19 mi. (Regensburg, Germany, +144 more cities)

University Clinic Regensburg

EGFR Exon 20 Insertion

Non-Squamous Non-Small Cell Lung Carcinoma

mobocertinib

targeted therapy

Efficacy, Safety, and Tolerability of V937 Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)

~19 mi. (Regensburg, Germany, +25 more cities)

Universitaetsklinikum Regensburg ( Site 2007)

Melanoma

coxsackievirus A21, +1 more drug

immunotherapy

A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

~19 mi. (Regensburg, Germany, +16 more cities)

Site DE49003

FLT3 ITD

Acute Myeloid Leukemia

cytarabine, +3 more drugs

chemotherapy, +2 more types

TCR-engineered T Cells in Solid Tumors: IMA202-101

~19 mi. (Regensburg, Germany, +8 more cities)

Universitätsklinikum Regensburg, Franz-Josef-Strauß-Allee 11

MAGEA1 Expression

Malignant Solid Tumor

aldesleukin, +3 more drugs

cellular therapy, +3 more types

TCR-engineered T Cells in Solid Tumors

~19 mi. (Regensburg, Germany, +7 more cities)

Universitätsklinikum Regensburg, Franz-Josef-Strauß-Allee 11

Malignant Solid Tumor

aldesleukin, +4 more drugs

cellular therapy, +3 more types

A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer

~48 mi. (Amberg, Germany, +144 more cities)

GSK Investigational Site

Endometrial Carcinoma

carboplatin, +3 more drugs

chemotherapy, +2 more types

Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

~52 mi. (Landshut, Germany, +94 more cities)

Klinikum Landshur GmbH

HER2 Negative

Breast Carcinoma

sacituzumab govitecan

chemotherapy, +1 more type

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

~60 mi. (Neumarkt in der Oberpfalz, Germany, +130 more cities)

Klinikum Weiden ( Site 0259)

Bladder Urothelial Carcinoma

BCG solution, +1 more drug

immunotherapy

A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

~73 mi. (München, Germany, +192 more cities)

Klinikum der Universität München Großhadern, +1 more facility

ER Positive, +1 more biomarker

Breast Carcinoma

abemaciclib, +1 more drug

hormone therapy, +1 more type